
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1562096
This article is part of the Research Topic Unveiling the Future of Antibiotics: Exploring the WHO Priority List of Antibiotic-Resistant Bacteria for Discovery, Research, and Development of Novel Therapeutics View all 4 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Carbapenem-resistant Klebsiella pneumoniae (CRKp) infection poses a significant global public health challenge, with the misuse of antibiotics further contributing to the development of resistance and triggering harmful inflammatory responses. Outer membrane vesicle (OMVs) released by CRKp under sub-lethal concentration of MEM pressure (KOMV-MEM) exhibit enhanced virulence and greater efficiency in transferring resistance genes. This study confirmed that the increased inflammation and bacterial load observed in CRKp-infected mice under MEM pressure were attributable to the high virulence of KOMV-MEM. We concurrently investigated the inhibitory effects of chlorogenic acid (CA) on KOMV-MEM characteristics and its protective role in KOMV-MEM infected mice. Based on LC-MS proteomic analysis of vesicles, we screened for potential targets of KOMV-MEM in promoting macrophage (MØ) pyroptosis pathways and inducing resistance gene transfer. Computational predictions and experimental validation revealed that CA inhibits pyroptosis by reducing MØ capture of KOMV-MEM via blocking the interaction between GroEL and LOX-1. Furthermore, CA was found to prevent the spread of resistance genes by disrupting the conjugation and transfer processes between KOMV-MEM and recipient bacteria. Finally, our in vitro and in vivo studies showed that CA can inhibit KOMV-MEM resistance enzymes, thereby preventing the hydrolysis of MEM in the environment and depriving susceptible bacteria of protection. In summary, these results provide the first confirmation that CA can inhibit the virulence and transmission of drug resistance in KOMV-MEM. This underscores that CA treatment for CRKp infection is a promising antimicrobial strategy.
Keywords: Outer membrane vesicle, carbapenem-resistant Klebsiella pneumoniae, Resistance gene transfer, Cell pyroptosis, Chlorogenic Acid
Received: 16 Jan 2025; Accepted: 07 Mar 2025.
Copyright: © 2025 Wang, Wan, Yu, Du, Zhou, Wan and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jiehong Yang, Zhejiang Chinese Medical University, Hangzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.